A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

肿瘤微环境 生物 CD8型 癌症研究 细胞毒性T细胞 免疫学 免疫系统 T细胞 免疫疗法 体外 生物化学
作者
Sandra Van Lint,Alexander Van Parys,Bram Van Den Eeckhout,Niels Vandamme,Stéphane Plaisance,Annick Verhee,Dominiek Catteeuw,Elke Rogge,Jennifer De Geest,Nele Vanderroost,Jana Roels,Yvan Saeys,Gilles Uzé,Niko Kley,Anje Cauwels,Jan Tavernier
出处
期刊:Molecular Cancer [BioMed Central]
卷期号:22 (1) 被引量:5
标识
DOI:10.1186/s12943-023-01908-6
摘要

Abstract Despite major improvements in immunotherapeutic strategies, the immunosuppressive tumor microenvironment remains a major obstacle for the induction of efficient antitumor responses. In this study, we show that local delivery of a bispecific Clec9A-PD-L1 targeted type I interferon (AcTaferon, AFN) overcomes this hurdle by reshaping the tumor immune landscape. Treatment with the bispecific AFN resulted in the presence of pro-immunogenic tumor-associated macrophages and neutrophils, increased motility and maturation profile of cDC1 and presence of inflammatory cDC2. Moreover, we report empowered diversity in the CD8 + T cell repertoire and induction of a shift from naive, dysfunctional CD8 + T cells towards effector, plastic cytotoxic T lymphocytes together with increased presence of NK and NKT cells as well as decreased regulatory T cell levels. These dynamic changes were associated with potent antitumor activity. Tumor clearance and immunological memory, therapeutic immunity on large established tumors and blunted tumor growth at distant sites were obtained upon co-administration of a non-curative dose of chemotherapy. Overall, this study illuminates further application of type I interferon as a safe and efficient way to reshape the suppressive tumor microenvironment and induce potent antitumor immunity; features which are of major importance in overcoming the development of metastases and tumor cell resistance to immune attack. The strategy described here has potential for application across to a broad range of cancer types.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
patom发布了新的文献求助10
刚刚
1秒前
3秒前
NexusExplorer的应助被huanhuan采纳,获得10
3秒前
研友_VZG7GZ的应助被zyz采纳,获得10
3秒前
所所的应助被柔柔柔柔子采纳,获得10
3秒前
轻松的友灵完成签到,获得积分10
4秒前
领导范儿的应助被sharon采纳,获得10
5秒前
hi_traffic发布了新的文献求助10
5秒前
椰子水水完成签到,获得积分20
5秒前
秋风的应助被jerrychen采纳,获得10
5秒前
周小鱼发布了新的文献求助10
5秒前
5秒前
在水一方的应助被Lotus采纳,获得10
6秒前
CodeCraft的应助被科研通管家采纳,获得10
6秒前
内向易文发布了新的文献求助10
6秒前
6秒前
Pf1314发布了新的文献求助100
6秒前
Hello的应助被科研通管家采纳,获得10
6秒前
fantasy的应助被科研通管家采纳,获得10
6秒前
Jyu的应助被科研通管家采纳,获得10
6秒前
6秒前
6秒前
NexusExplorer的应助被科研通管家采纳,获得10
7秒前
情怀的应助被科研通管家采纳,获得10
7秒前
7秒前
Owen的应助被科研通管家采纳,获得10
7秒前
桐桐的应助被科研通管家采纳,获得10
7秒前
酷波er的应助被科研通管家采纳,获得10
7秒前
7秒前
ding的应助被科研通管家采纳,获得10
7秒前
脑洞疼的应助被长情的初曼采纳,获得10
7秒前
在水一方的应助被科研通管家采纳,获得10
7秒前
小晶发布了新的文献求助10
7秒前
Jyu的应助被科研通管家采纳,获得10
7秒前
molihuakai的应助被科研通管家采纳,获得10
8秒前
慕青的应助被科研通管家采纳,获得10
8秒前
fantasy的应助被科研通管家采纳,获得30
8秒前
思源的应助被科研通管家采纳,获得100
8秒前
上官若男的应助被科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175707
求助须知:如何正确求助?哪些是违规求助? 9567353
关于积分的说明 21792214
捐赠科研通 7770334
什么是DOI,文献DOI怎么找? 3431908
关于科研通互助平台的介绍 2556260
邀请新用户注册赠送积分活动 2477417